300896 爱美客
已收盘 01-30 15:00:00
资讯
新帖
简况
爱美客（300896）披露控股子公司重大仲裁进展公告，1月30日股价下跌3.22%
证券之星 · 21分钟前
爱美客（300896）披露控股子公司重大仲裁进展公告，1月30日股价下跌3.22%
爱美客：公司经销的肉毒毒素产品最近取得药品注册证书，公司正在制定相关的销售策略
每日经济新闻 · 21:15
爱美客：公司经销的肉毒毒素产品最近取得药品注册证书，公司正在制定相关的销售策略
爱美客子公司REGEN重大仲裁临时措施被撤销，AestheFill产品销售限制解除
中金财经 · 17:14
爱美客子公司REGEN重大仲裁临时措施被撤销，AestheFill产品销售限制解除
爱美客：公司会根据上一年度业绩考核结果及新一期战略目标，评估是否启动新一轮激励计划
证券之星 · 01-29 20:48
爱美客：公司会根据上一年度业绩考核结果及新一期战略目标，评估是否启动新一轮激励计划
爱美客：公司经销的肉毒产品最近取得药品注册证书
证券之星 · 01-29 17:00
爱美客：公司经销的肉毒产品最近取得药品注册证书
爱美客：米诺地尔已经获得国家药监局的药品注册证书
证券之星 · 01-29 17:00
爱美客：米诺地尔已经获得国家药监局的药品注册证书
爱美客：公司始终坚持长期可持续发展理念
证券之星 · 01-28 18:06
爱美客：公司始终坚持长期可持续发展理念
股市必读：爱美客（300896）1月23日董秘有最新回复
证券之星 · 01-26
股市必读：爱美客（300896）1月23日董秘有最新回复
爱美客：公司重视投资者关系，一直在遵守与上市公司信息披露相关的法律、法规的前提下，及时对投资者建议及问题进行客观详实
证券之星 · 01-23
爱美客：公司重视投资者关系，一直在遵守与上市公司信息披露相关的法律、法规的前提下，及时对投资者建议及问题进行客观详实
股市必读：爱美客（300896）1月21日董秘有最新回复
证券之星 · 01-22
股市必读：爱美客（300896）1月21日董秘有最新回复
爱美客：截至2026年1月20日股东人数为61,728户
证券之星 · 01-21
爱美客：截至2026年1月20日股东人数为61,728户
股市必读：爱美客（300896）1月19日董秘有最新回复
证券之星 · 01-20
股市必读：爱美客（300896）1月19日董秘有最新回复
爱美客：公司凭借全方位且具有差异化的产品矩阵来满足用户多元化的需求
证券日报 · 01-19
爱美客：公司凭借全方位且具有差异化的产品矩阵来满足用户多元化的需求
股市必读：爱美客（300896）1月16日董秘有最新回复
证券之星 · 01-19
股市必读：爱美客（300896）1月16日董秘有最新回复
爱美客：公司主营业务为Ⅲ类医疗器械
证券之星 · 01-15
爱美客：公司主营业务为Ⅲ类医疗器械
股市必读：爱美客（300896）1月14日董秘有最新回复
证券之星 · 01-15
股市必读：爱美客（300896）1月14日董秘有最新回复
2025年医美行业盘点 从“流量驱动”到“价值回归”
新快报 · 01-13
2025年医美行业盘点 从“流量驱动”到“价值回归”
爱美客：截至2026年1月9日股东人数为61,468户
证券之星 · 01-12
爱美客：截至2026年1月9日股东人数为61,468户
爱美客：司美格鲁肽注射液项目处于临床试验阶段
证券之星 · 01-09
爱美客：司美格鲁肽注射液项目处于临床试验阶段
爱美客：积极布局Hutox®上市前准备工作
证券之星 · 01-09
爱美客：积极布局Hutox®上市前准备工作
加载更多
公司概况
公司名称：
爱美客技术发展股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-09-28
主营业务：
爱美客技术发展股份有限公司的主营业务是生物医用材料及生物医药的研发、生产和销售。公司的主要产品是Ⅲ类医疗器械、注射类皮肤填充剂产品。
发行价格：
118.27
{"stockData":{"symbol":"300896","market":"SZ","secType":"STK","nameCN":"爱美客","latestPrice":139.73,"timestamp":1769756592000,"preClose":144.38,"halted":0,"volume":3760011,"delay":0,"changeRate":-0.0322,"floatShares":209000000,"shares":303000000,"eps":4.8427,"marketStatus":"已收盘","change":-4.65,"latestTime":"01-30 15:00:00","open":142.98,"high":143.2,"low":139.67,"amount":531000000,"amplitude":0.0244,"askPrice":139.73,"askSize":19,"bidPrice":139.72,"bidSize":57,"shortable":0,"etf":0,"ttmEps":4.8427,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":5,"adr":0,"adjPreClose":144.38,"symbolType":"stock","openAndCloseTimeList":[[1769736600000,1769743800000],[1769749200000,1769756400000]],"highLimit":158.82,"lowLimit":129.94,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":302592061,"isCdr":false,"pbRate":5.91,"roa":"--","peRate":28.853739,"roe":"14.18%","epsLYR":6.5,"committee":0.505208,"marketValue":42281000000,"turnoverRate":0.018,"status":1,"floatMarketCap":29147000000},"requestUrl":"/m/hq/s/300896","defaultTab":"news","newsList":[{"id":"2607049238","title":"爱美客（300896）披露控股子公司重大仲裁进展公告，1月30日股价下跌3.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607049238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607049238?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:18","pubTimestamp":1769782697,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，爱美客报收于139.73元，较前一交易日下跌3.22%，最新总市值为422.81亿元。该股当日开盘142.98元，最高143.2元，最低139.67元，成交额达5.31亿元，换手率为1.8%。爱美客于近日披露《关于公司控股子公司REGEN Biotech, Inc.重大仲裁的进展公告》。公告显示，2025年8月14日，爱美客控股子公司REGEN公司因与达透公司经销合同纠纷被提起仲裁，深圳国际仲裁院于2025年9月10日作出临时措施决定，限制REGEN公司在中国境内销售AestheFill产品及向第三方供货。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2607045467","title":"爱美客：公司经销的肉毒毒素产品最近取得药品注册证书，公司正在制定相关的销售策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2607045467","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607045467?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:15","pubTimestamp":1769778900,"startTime":"0","endTime":"0","summary":"每经AI快讯，爱美客（300896.SZ）1月30日在投资者互动平台表示，公司经销的肉毒毒素产品最近取得药品注册证书，公司正在制定相关的销售策略，关于产品销售情况敬请关注公司公告。（文章来源：每日经济新闻）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-30/doc-inhkazcc3483166.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-30/doc-inhkazcc3483166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2607139200","title":"爱美客子公司REGEN重大仲裁临时措施被撤销，AestheFill产品销售限制解除","url":"https://stock-news.laohu8.com/highlight/detail?id=2607139200","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607139200?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:14","pubTimestamp":1769764446,"startTime":"0","endTime":"0","summary":"中访网数据 爱美客技术发展股份有限公司于2026年1月30日发布公告，披露其控股子公司REGEN Biotech, Inc.涉及的重大仲裁案件取得新进展。此前，深圳国际仲裁院紧急仲裁员曾于2025年9月10日作出决定，要求REGEN公司在仲裁裁决前不得自行在中国销售AestheFill产品、不得否认达透公司的独家经销商地位并需继续供货。2026年1月29日，REGEN公司收到仲裁庭作出的决定，仲裁庭决定不再实施上述临时措施，这意味着针对AestheFill产品的销售限制等措施已被撤销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260130/31986994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2607208225","title":"爱美客：公司会根据上一年度业绩考核结果及新一期战略目标，评估是否启动新一轮激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2607208225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607208225?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:48","pubTimestamp":1769690919,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客01月28日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，2026年公司是否有回购或股权激励？感谢您对公司的关注与建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900040730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2607576702","title":"爱美客：公司经销的肉毒产品最近取得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2607576702","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607576702?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:00","pubTimestamp":1769677232,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客01月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司2026年1月获批的肉毒素产品是当前的业绩增长点关键。如何平衡直销与经销的利益分配？公司经销的肉毒产品最近取得药品注册证书，公司正在制定相关的销售策略，关于产品销售情况敬请关注公司公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900027746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2607026457","title":"爱美客：米诺地尔已经获得国家药监局的药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2607026457","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607026457?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:00","pubTimestamp":1769677231,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客01月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司2026年的新产品是未来的增长引擎。米诺地尔的临床试验进展？米诺地尔已经获得国家药监局的药品注册证书。目前该产品的市场推广工作正在有序推进。嗗科拉是公司推出的软骨仿生材料，与濡白天使相比较，两款产品的核心成分、产品定位及适应症等方面均存在差异，可以满足不同消费群体的需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900027745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2606379279","title":"爱美客：公司始终坚持长期可持续发展理念","url":"https://stock-news.laohu8.com/highlight/detail?id=2606379279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606379279?lang=zh_cn&edition=full","pubTime":"2026-01-28 18:06","pubTimestamp":1769594764,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)01月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司将如何在品牌、研发、学术、合作、市场教育和合规等方面协同发力，以加速市场认可并提升核心竞争力？爱美客回复：尊敬的投资者您好，公司始终坚持长期可持续发展理念，聚焦主营业务，持续优化产品结构，强化创新驱动，不断提升核心竞争力与抗风险能力，夯实企业内在价值，推动业绩稳步增长，切实维护广大股东权益。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800031858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2606263075","title":"股市必读：爱美客（300896）1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606263075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606263075?lang=zh_cn&edition=full","pubTime":"2026-01-26 02:39","pubTimestamp":1769366350,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，爱美客报收于142.93元，上涨0.94%，换手率1.45%，成交量3.02万手，成交额4.33亿元。董秘最新回复投资者： 我建议更换董秘。敷衍式回复股东提问。当日关注点来自交易信息汇总：1月23日主力资金净流出567.61万元，游资资金净流出1527.19万元，散户资金净流入2094.79万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2605421286","title":"爱美客：公司重视投资者关系，一直在遵守与上市公司信息披露相关的法律、法规的前提下，及时对投资者建议及问题进行客观详实","url":"https://stock-news.laohu8.com/highlight/detail?id=2605421286","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605421286?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:06","pubTimestamp":1769151978,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)01月23日在投资者关系平台上答复投资者关心的问题。投资者提问：我建议更换董秘。敷衍式回复股东提问。没有诚意。爱美客回复：尊敬的投资者您好，公司重视投资者关系，一直在遵守与上市公司信息披露相关的法律、法规的前提下，及时对投资者建议及问题进行客观详实回复。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300019249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2605481714","title":"股市必读：爱美客（300896）1月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605481714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605481714?lang=zh_cn&edition=full","pubTime":"2026-01-22 01:01","pubTimestamp":1769014874,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，爱美客报收于144.6元，下跌0.15%，换手率1.26%，成交量2.63万手，成交额3.78亿元。董秘最新回复投资者： 董秘您好！谢谢董秘： 尊敬的投资者您好，截至2026年1月20日，公司股东人数为61,728户。当日关注点来自交易信息汇总：1月21日主力资金净流出3389.11万元，散户资金净流入4344.7万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200000435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2605717727","title":"爱美客：截至2026年1月20日股东人数为61,728户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605717727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605717727?lang=zh_cn&edition=full","pubTime":"2026-01-21 17:33","pubTimestamp":1768987986,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年一月 20日公司的股东总数是多少？谢谢爱美客回复：尊敬的投资者您好，截至2026年1月20日，公司股东人数为61,728户。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100029068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2604220137","title":"股市必读：爱美客（300896）1月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604220137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604220137?lang=zh_cn&edition=full","pubTime":"2026-01-20 01:33","pubTimestamp":1768843987,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，爱美客报收于147.16元，上涨0.58%，换手率1.4%，成交量2.92万手，成交额4.31亿元。董秘最新回复投资者： 你好董秘 贵公司有抗衰老技术吗 如何让脸老得慢一点让人的“面容”看起来更年轻。投资者： 爱美客公司近期会披露2025年度的业绩预告吗？当日关注点来自交易信息汇总：1月19日主力资金净流入1601.06万元，显示主力对爱美客的积极布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000000628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2604136365","title":"爱美客：公司凭借全方位且具有差异化的产品矩阵来满足用户多元化的需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2604136365","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604136365?lang=zh_cn&edition=full","pubTime":"2026-01-19 20:34","pubTimestamp":1768826040,"startTime":"0","endTime":"0","summary":"证券日报网讯 1月19日，爱美客在互动平台回答投资者提问时表示，截至目前公司已形成了基于透明质酸钠的系列皮肤填充剂、基于聚乳酸的皮肤填充剂、基于聚对二氧环己酮面部埋植线，以及基于神经除皱肉毒毒素生物制剂的丰富的产品线。公司凭借全方位且具有差异化的产品矩阵来满足用户多元化的需求。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-19/doc-inhhwavp7776620.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-19/doc-inhhwavp7776620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2604794179","title":"股市必读：爱美客（300896）1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604794179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604794179?lang=zh_cn&edition=full","pubTime":"2026-01-19 01:03","pubTimestamp":1768755790,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，爱美客报收于146.31元，下跌1.68%，换手率1.68%，成交量3.5万手，成交额5.15亿元。董秘最新回复投资者： 你好，请问你们的医疗器械中有无计划融合AI技术？市场有很多AI硬件很火爆董秘： 尊敬的投资者您好，公司暂未有AI方面的技术与业务计划，感谢您的关注。当日关注点来自交易信息汇总：1月16日主力资金净流出6499.78万元，散户资金净流入4594.62万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900000383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2603677369","title":"爱美客：公司主营业务为Ⅲ类医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2603677369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603677369?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:24","pubTimestamp":1768465487,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问：你们有没有使用AI技术进行医疗美容？爱美客回复：尊敬的投资者您好，公司主营业务为Ⅲ类医疗器械，是Ⅲ类医疗器械的提供商。公司下游客户主要为有资质的医疗美容机构及经销商，下游客户根据法律法规及其合法资质独立对外开展医疗服务。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500024154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1574","159883","BK1100","09996","09997","300896","BK1222","BK1583"],"gpt_icon":0},{"id":"2603645089","title":"股市必读：爱美客（300896）1月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603645089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603645089?lang=zh_cn&edition=full","pubTime":"2026-01-15 01:48","pubTimestamp":1768412893,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘，爱美客报收于151.77元，上涨0.3%，换手率2.88%，成交量6.01万手，成交额9.15亿元。董秘最新回复投资者： 请问爱美客注射用A型肉毒毒素产品上市，有隆重大型的新品发布会吗？预计在2026年哪个季度上市？当日关注点来自交易信息汇总：1月14日主力资金净流入1776.6万元，显示主力对爱美客的积极布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500001102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2603520181","title":"2025年医美行业盘点 从“流量驱动”到“价值回归”","url":"https://stock-news.laohu8.com/highlight/detail?id=2603520181","media":"新快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603520181?lang=zh_cn&edition=full","pubTime":"2026-01-13 08:41","pubTimestamp":1768264860,"startTime":"0","endTime":"0","summary":"2025年的医美市场格外热闹，医美行业在监管风暴、价格厮杀与技术突破中完成深度洗牌。行业泡沫退去后，医美行业正从“流量驱动”转向“价值回归”，真正的技术创新、合规经营，才是医美行业长远发展的底层逻辑。2025年10月，京东医美首个自营独立门店正式开业，主打“正品保障”和“价格透明”，旨在解决行业长期存在的药械来源不明、价格不透明等痛点。2025年，“赴韩医美特种兵”成为年轻群体消费新潮流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113084200a7135d0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113084200a7135d0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0315179316.USD","LU0052750758.USD","LU1328277881.USD","LU0348805143.USD","LU0791590937.USD","LU0149721374.USD","LU0828237510.HKD","BK1588","LU0791591158.USD","LU0359201612.USD","LU0572944931.SGD","LU0345776255.USD","LU0456827905.SGD","LU1023057109.AUD","LU0417516738.SGD","LU0417516902.SGD","LU1642822792.SGD","LU0871576103.HKD","LU1770036033.HKD","LU0140636845.USD","LU0320764755.SGD","LU0469268626.HKD","LU0865486749.SGD","LU0314109678.HKD","300896","LU0228659784.USD","LU1808992512.USD","LU0588546209.SGD","BK1502","LU0588545730.USD","LU2039709279.SGD","BK1249","LU1794554557.SGD","LU0029875118.USD","LU2242644610.SGD","LU0359201885.HKD","LU1282649067.USD","LU0672654166.SGD","600200","LU0594300419.USD","LU2257852520.SGD","BK1619","LU0708995583.HKD","LU0868486357.SGD","LU1719994722.HKD","LU0163747925.USD","IE00B29SXG58.USD","LU1481107354.HKD","LU0259732245.USD","LU0499858602.USD","LU1366334651.USD","LU1813983027.USD","LU0359202008.SGD","LU1251922891.USD","LU0320764599.SGD","LU0431992006.USD","LU0588545490.SGD","BK1591","LU0456842615.SGD","LU0307460666.USD","LU0384037296.USD","LU0588545904.SGD","LU1224444064.USD","LU0164880469.USD","LU0345775950.USD","LU0499858438.USD","IE00BGV7N243.SGD","LU0370786039.SGD","LU0051755006.USD","SG9999002828.SGD","LU1044875133.USD","LU0211977185.USD","LU0348735423.USD","LU0228367735.SGD","LU0348825331.USD","09618","LU0456846285.SGD","LU1282651121.HKD","LU1044874839.SGD","BK1575","LU0531971595.HKD","LU1282651048.USD","LU1044876610.USD","LU0128522157.USD","IE0032431581.USD","SG9999002562.SGD","SG9999001226.SGD","89618","LU1303224171.USD","LU0039217434.USD","LU0048580855.USD","LU1282649810.SGD","LU0315178854.USD","LU1770034418.SGD","LU1366334578.USD","BK1615","LU0543330483.HKD","BK1142","LU0084288322.USD","LU0164865239.USD","LU1720050803.USD","LU0327786744.USD","LU0488056044.USD","BK1610","LU0650527681.SGD","IE00B3M56506.USD","LU0293314216.USD","LU0231483743.USD"],"gpt_icon":1},{"id":"2602059942","title":"爱美客：截至2026年1月9日股东人数为61,468户","url":"https://stock-news.laohu8.com/highlight/detail?id=2602059942","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602059942?lang=zh_cn&edition=full","pubTime":"2026-01-12 15:18","pubTimestamp":1768202298,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)01月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年一月 9日公司的股东总数是多少？谢谢爱美客回复：尊敬的投资者您好，截至2026年1月9日，公司股东人数为61,468户。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200014557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2602832142","title":"爱美客：司美格鲁肽注射液项目处于临床试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2602832142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602832142?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:54","pubTimestamp":1767952464,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)01月09日在投资者关系平台上答复投资者关心的问题。投资者提问：恭喜公司注射用A型肉毒毒素产品获批，请问司美格鲁肽和A型重组人源化胶原蛋白产品研发进度如何？爱美客回复：尊敬的投资者您好，公司司美格鲁肽注射液项目目前处于临床试验阶段。公司研发项目相关情况您可查阅公司《2025年半年度报告》中“研发项目进展”部分。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900029388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2602214493","title":"爱美客：积极布局Hutox®上市前准备工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2602214493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602214493?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:54","pubTimestamp":1767952463,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客01月09日在投资者关系平台上答复投资者关心的问题。请问推广节奏：获批后1个月内会启动哪些核心活动？3个月内能否完成核心城市的渠道覆盖？6个月内的目标终端覆盖率是多少？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900029387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1769783915243,"stockEarnings":[{"period":"1week","weight":0.0196},{"period":"1month","weight":0.0222},{"period":"3month","weight":-0.0981},{"period":"6month","weight":-0.2124},{"period":"1year","weight":-0.1263},{"period":"ytd","weight":0.0188}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0486},{"period":"3month","weight":0.0514},{"period":"6month","weight":0.168},{"period":"1year","weight":0.2791},{"period":"ytd","weight":0.0477}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱美客技术发展股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"61728人(较上一季度增加0.42%)","perCapita":"3379股","listingDate":"2020-09-28","address":"北京市昌平区科技园区白浮泉路10号北控科技大厦4层416B室","registeredCapital":"30259万元","survey":" 爱美客技术发展股份有限公司的主营业务是生物医用材料及生物医药的研发、生产和销售。公司的主要产品是Ⅲ类医疗器械、注射类皮肤填充剂产品。","listedPrice":118.27},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱美客,300896,爱美客股票,爱美客股票老虎,爱美客股票老虎国际,爱美客行情,爱美客股票行情,爱美客股价,爱美客股市,爱美客股票价格,爱美客股票交易,爱美客股票购买,爱美客股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}